Company intelligence / Profile preview

AG Associates

Columbia, Maryland, United States

Ownership: Private
Development stage: Other

Overview

A&G Pharmaceutical is a precision medicine biotechnology company focused on the development of theranostic products for cancer and neurodegenerative diseases. The company's core technology centers on progranulin (GP88), a critical growth and survival factor that plays a key role in tumor progression and drug resistance. A&G's pipeline includes the lead therapeutic candidate AG01, a monoclonal antibody targeting GP88, and the PrecisionMed GP88 diagnostic test for breast cancer. By integrating diagnostics and therapeutics, the company aims to provide personalized treatment options for patients with high unmet medical needs.

Therapeutic areas: OncologyNeurology
Modalities: Monoclonal antibodyDiagnostic
Industry: Biotech

Beyond the preview

Go deeper on AG Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AG Associates.

Explore the full profile